A
Autonomix Medical, Inc. (AMIX)
NCM – Real Time Price. Currency in USD
0.33
-0.01 (-1.64%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
0.33
-0.01 (-1.64%)
At close: May 12, 2026, 4:00 PM EDT
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company’s technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas.
| Name | Position |
|---|---|
| Dr. Robert Schwartz M.D. | Co-Founder & Chief Medical Officer |
| Mr. Bradley Hauser | CEO & President |
| Mr. David A. Robins | Co-Founder & Director |
| Mr. Landy Toth | Co-Founder & Chief Technology Officer |
| Mr. Trent N. Smith CPA | Executive VP & CFO |
| Mr. Walter V. Klemp | Executive Chairman |
| Ms. Jennifer Cook | Chief Business Officer |
| Ms. Lori H. Bisson | Executive Vice Chairman |
| Date | Type | Document |
|---|---|---|
| 2026-04-02 | S-8 | amix20260326_s8.htm |
| 2026-02-11 | 10-Q | amix20251231_10q.htm |
| 2026-01-16 | 8-K | amix20260114_8k.htm |
| 2026-01-09 | 8-K | amix20260108_8k.htm |
| 2025-11-26 | S-3 | amix20251121_s3.htm |
| 2025-11-19 | 8-K | amix20251118c_8k.htm |
| 2025-11-12 | 10-Q | amix20250930_10q.htm |
| 2025-11-03 | 8-K | amix20251030_8k.htm |
| 2025-09-29 | CORRESP | filename1.htm |
| 2025-09-23 | S-1 | amix20250914_s1.htm |